{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:44:22Z","timestamp":1786358662874,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.cjca.2012.08.008","type":"journal-article","created":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T21:04:22Z","timestamp":1350939862000},"page":"213-218","source":"Crossref","is-referenced-by-count":18,"title":["Antithrombotic Therapy After Coronary Stenting in Patients With Nonvalvular Atrial Fibrillation"],"prefix":"10.1016","volume":"29","author":[{"given":"Kay W.","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Freixa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Osten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Ing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Horlick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Seidelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladim\u00edr","family":"D\u017eav\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2012.08.008_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cjca.2011.12.011","article-title":"Management and outcome of acute coronary syndrome patients in relation to prior history of atrial fibrillation","volume":"28","author":"Al Khdair","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.08.008_bib2","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.08.008_bib3","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/CIRCULATIONAHA.106.177292","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2012.08.008_bib4","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.290.20.2685","article-title":"Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?","volume":"290","author":"Go","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.08.008_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cjca.2012.01.021","article-title":"Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate\/rhythm control","volume":"28","author":"Skanes","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.08.008_bib6","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.08.008_bib7","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.08.008_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jacc.2007.10.002","article-title":"2007 focused update of the ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"51","author":"King","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl A","key":"10.1016\/j.cjca.2012.08.008_bib9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cjca.2010.12.015","article-title":"The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines","volume":"27","author":"Bell","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.08.008_bib10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000089548","article-title":"Aspirin, warfarin and a thienopyridine for acute coronary syndromes","volume":"105","author":"Konstantino","year":"2006","journal-title":"Cardiology"},{"key":"10.1016\/j.cjca.2012.08.008_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ahj.2003.06.004","article-title":"Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation","volume":"147","author":"Orford","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2012.08.008_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1540-8183.2005.04065.x","article-title":"Evaluation of safety of warfarin in combination with antiplatelet therapy for patients treated with coronary stents for acute myocardial infarction","volume":"18","author":"Mattichak","year":"2005","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.cjca.2012.08.008_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ccd.20733","article-title":"Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention","volume":"68","author":"Porter","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2012.08.008_bib14","first-page":"162","article-title":"Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding","volume":"18","author":"Khurram","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.cjca.2012.08.008_bib15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1592\/phco.27.5.691","article-title":"Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy","volume":"27","author":"DeEugenio","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cjca.2012.08.008_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/eurheartj\/ehl488","article-title":"Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting","volume":"28","author":"Karjalainen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2012.08.008_bib17","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/eurheartj\/ehm186","article-title":"Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?","volume":"28","author":"Nguyen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2012.08.008_bib18","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2007.11.035","article-title":"Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis","volume":"51","author":"Ruiz-Nodar","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.08.008_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jcin.2007.11.004","article-title":"Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation","volume":"1","author":"Rogacka","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2012.08.008_bib20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1253\/circj.CJ-09-0880","article-title":"Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation","volume":"74","author":"Gao","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.cjca.2012.08.008_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1378\/chest.08-0350","article-title":"Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting","volume":"134","author":"Manzano-Fernandez","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2012.08.008_bib22","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/europace\/eup131","article-title":"Dilemma of antithrombotic therapy in anticoagulated atrial fibrillation patients squeezed between thrombosis and bleeding events: a single-centre experience","volume":"11","author":"Halbfass","year":"2009","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2012.08.008_bib23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.7326\/0003-4819-155-9-201111010-00004","article-title":"Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable","volume":"155","author":"Connolly","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2012.08.008_bib24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"Stroke Prevention in Atrial Fibrillation Study","volume":"84","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2012.08.008_bib25","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.08.008_bib26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.08.008_bib27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X12012123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X12012123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T20:23:30Z","timestamp":1542659010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X12012123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0828282X12012123"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2012.08.008","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}